Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia (Q40568145)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2002

Language	Label	Description	Also known as
English	Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia	scientific article published on January 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nina Cavalli-Björkman

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Eva Osby

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jeanette Lundin

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mats Kalin

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Anders Osterborg

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Astrid Gruber

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

277-280

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Community respiratory virus infections following lung transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus Infection in Pediatric Liver Transplant Recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal disseminated adenoviral infection in a renal transplant patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus infections in hematopoietic stem cell transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenoviruses in the immunocompromised host

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus infections in adult recipients of blood and marrow transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus infection in the immunocompromised patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The implications for childhood leukemia of infection with adenovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction to adenoviruses: an overview of morphology, classification and epidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12512923

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:19:4:277

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40568145&oldid=2203794021"